Partner with a Twist NGS ProLab

Synlab is primarily a medical diagnostic lab but their sequencing services are also available for R&D and collaboration with a few research projects. They have more than 25 years of experience in Genetics, and perform any genetic test requested,  having specific expertise in Oncology, Hemato-Oncology, Pre-Natal Diagnosis, and Rare Disease diagnosis. They have expertise in Exome analysis of Diagnostic NGS Panels or WES in all several fields of Medical Specialities.  Being oriented to clinical diagnosis their TATs are convenient to help a rapid diagnostic result as well as differential diagnosis.

Since opening its doors in 2008, HudsonAlpha has further secured its role as a global leader in biotechnology and genomic research. They’ve made discoveries in ALS, childhood genetic disorders and kidney cancer; expanded research in bipolar and schizophrenia and continued critical research in other devastating conditions, including cancer, Parkinson’s, lupus, multiple sclerosis and more.
For the Clevenger lab, the main goal is to bridge the gap between science and nature by more rapidly introducing beneficial traits into cultivated crops farmers can plant on their land. To do this, the team is developing better computational tools to help identify selection markers for the traits, and new, rapid breeding practices to introduce these markers into existing crop lines.

GENEWIZ, from Azenta Life Sciences, a global leader in genomic services. GENEWIZ empowers research by providing high-quality, precision-based solutions from research use only to pre-clinical/clinical, enabling scientists to make breakthroughs faster and more efficiently. Key services include Next Generation and Sanger sequencing, gene synthesis, gene-to-discovery solutions including antibody production, viral packaging and mRNA synthesis. For more information visit www.Genewiz.com.
Azenta, Inc. (Nasdaq: AZTA) is a leading provider of life sciences solutions worldwide, enabling life science organizations around the world to bring impactful breakthroughs and therapies to market faster. Azenta is headquartered in Burlington, MA, with operations in North America, Europe and Asia.

We are a core facility based at The University of Leeds since 2009, offering efficient and flexible library preparation and sequencing services to both internal and external customers. We have cutting edge workflows for both Illumina and Oxford Nanopore sequencing. Our facility houses the Illumina MiSeq and NextSeq2000, along with the Oxford Nanopore PromethION 48, GridION and MinION sequencers. We have extensive experience in a wide range of tissue types and samples, and offer a tailored approach to project design, putting the end user at the centre of the decision-making process to support their research goals.

As a core facility, we work with a wide range of tissue types and samples and can offer a both Twist human Exome 2.0 and Twist RNA exome workflows. Other workflows can be discussed on request.

IntegraGen is a CAP-accredited and CLIA-certified laboratory based in Evry, France, specializing in genomic research and services that drive advancements in personalized medicine, oncology, and other biological fields. With over 20 years of experience in genomic analysis, IntegraGen focuses on the comprehensive study of DNA, RNA, and epigenetics, providing key insights into genetic variations and their biological significance. IntegraGen is a key partner for biopharmaceutical companies and CROs, as well as researchers in cancer research and rare genetic diseases, offering added value by working with precious and sensible samples (FFPE, plasma...).

The company delivers high-quality sequencing data and analysis services using cutting-edge technology and advanced bioinformatics, helping clients accelerate their projects and achieve more accurate genomic results. IntegraGen also develops innovative genomic data interpretation software, supporting the research community with advanced solutions.

TAKARA BIO INC. is a biotechnology company that provides products and services on next-generation sequencing, and manufacturing products of regenerative medicine and cell therapy. We provide a wide range of reagents, instruments, and services to support your research.
As your best partner, from basic technology to clinical development, we provide strong support for your research and development.

Laboratoire Cerba (CERBA) is a leading player in the French and international specialized clinical pathology market. As a European leader, CERBA supports healthcare professionals, academics, biotechnology, and pharmaceutical companies with an up-to-date portfolio of in vitro diagnostic tests, and genetics services. Expert in next-generation sequencing diagnostics, CERBA conducts Whole Exome Sequencing and NGS Panels in the context of Prenatal and Post-Natal diagnosis of Rare Diseases, Oncology, Haematology as well as Infectious Diseases. With a cutting-edge next-generation sequencing platform and highly qualified medical pathologists, CERBA serves as a reliable partner in industrial and/or medical pathology. Our ISO15189 laboratory ensures the delivery of high-quality results efficiently to our clients.

WeHealth, established in 2016, a leading brand in genetic disease screening and diagnosis, stream product detection, new mutation single gene blocking, and a three-level technical service platform for genetic testing of genetic diseases and birth defects prevention and control in Shanghai. We have established strong cooperative relations with hundreds of top medical institutions and experts in the industry, and can provide various complete solutions for genetic disease detection and scientific research.

Macrogen is the undisputed leader in genomic innovation, offering an unparalleled suite of solutions meticulously crafted to exceed the diverse needs of both research and clinical applications. By harnessing cutting-edge technology and the unrivaled expertise of its seasoned scientists, Macrogen provides exceptional guidance and support, setting new standards in academic research, pharmaceutical development, and the rapidly advancing field of personalized medicine.

Its exclusive strategic partnerships with industry-leading sequencing suppliers, including Illumina, Pacbio, Ultima Genomics, ONT, and Thermofisher Scientific, uniquely position Macrogen to deliver in-house sequencing services that leverage the latest technological advancements. Specializing in next-generation sequencing, microarray analysis, and bioinformatics, Macrogen consistently delivers high-quality data with unmatched precision and efficiency, offering profound insights into genetic variation, gene expression patterns, and molecular mechanisms that drive groundbreaking discoveries across various research domains.

Furthermore, its collaboration with TWIST Biosciences enables Macrogen to offer the most advanced library kits for Whole Exome and Custom Target Sequencing, such as Twist Core Exome, Twist Comprehensive, Twist 2.0, and Custom Panel Sequencing. Discover its top-selling library kits, detailed specifications, and essential information for sample preparation on its website: Macrogen Europe Next-Generation Sequencing.

Genomed SA is the undisputed leader of NGS in Poland and the provider of the most advanced NGS services, including a wide range and complex bioinformatic analysis. The Genomed offer is universal. In the diagnostic section, it includes genetic testing for individual patients, hospitals and clinics, physicians running private practice, centers performing clinical studies. And in its scientific part – it is addressed to the scientific community, pharmaceutical and biotechnology companies.

LIFE & BRAIN Genomics is one of the leading European service providers for omics analyses. We are dedicated to continually implementing new applications for generating and interpreting omics data to support our customers from academia, industry and the healthcare sector with innovative products and scientific expertise - from project planning to data analysis. Our services include nucleic acid extraction, sample preparation, genotyping, epigenetics, sequencing, proteomics and bioinformatics analysis.Genomics

We deliver early, actionable and personalised diagnoses across the care continuum to improve and save lives.
We discover, develop, and deliver accurate preventive healthcare solutions for cancer, cardiovascular, metabolic and infectious diseases, and make them accessible to all.

NovogeneAIT Genomics is a joint venture between Novogene and AIT Biotech focusing in Asia Pacific, Middle East, and Africa (AMEA) region. We are one of the largest NGS service providers for the research and clinical fields, with presence in Singapore, Japan, Australia, India, Hong Kong, the US, UK, and the Netherlands. We have global sequencing labs in Singapore, China, the US (at The University of California at Davis campus), and the UK (Cambridge).

Our company, focused on genetic services and products is leading the NGS segment through our automated library preparation, together with our Exonim 2.0 Exome product. This approach is available for Diagnostic and also for R and D.

Sampled is a next-generation laboratory that unlocks the valuable data in any biological sample. Through our integrated “Sampled SMART Lab” services, we can Store, Manage, Analyze, Research and Transport biological materials, offering partners a seamless solution for all research samples. Our vision is a world where we make it faster and easier for health innovators to improve human health, with a mission for Sampled SMART Labs to be behind every transformative health innovation. Sampled is headquartered in Piscataway, N.J. with labs across the US and Europe and partner labs in the Netherlands, China and Australia.

Riken Genesis Co., Ltd. is a provider of outsourced genetic analysis services designed to meet a wide range of research and clinical needs. Equipped with advanced analytical platforms and supported by experienced specialists, the company offers a comprehensive suite of services including accurate, rapid and cost-effective sequencing using next-generation sequencers, methylation and typing microarray analysis, protein expression testing via Olink technology with AI, Spatial gene expression profiling. And we have quality assurance system for CRO services, can support the development, regulatory filing, and marketing of diagnostics including companion diagnostics.

Founded in 2015, PathoNext GmbH is an according to DIN ISO 17025 accredited biotech company based and operating in Leipzig, Germany, that combines expertise in Genetics, Data Science, and Bioinformatics in order to improve cancer diagnosis and patient care by next-generation sequencing. Having fully automated DNA/RNA extraction and library preparation workflows in-house, PathoNext can handle fast and scalable sample processing, while delivering highest quality for data and results.

In addition to oncogenomic, PathoNext provides a variety of sequencing and Bioinformatics services and is a trusted cooperation partner for industry and academia.

GENEWIZ, from Azenta Life Sciences, a global leader in genomic services. GENEWIZ empowers research by providing high-quality, precision-based solutions from research use only to pre-clinical/clinical, enabling scientists to make breakthroughs faster and more efficiently. Key services include Next Generation and Sanger sequencing, gene synthesis, gene-to-discovery solutions including antibody production, viral packaging and mRNA synthesis. For more information visit www.Genewiz.com.
Azenta, Inc. (Nasdaq: AZTA) is a leading provider of life sciences solutions worldwide, enabling life science organizations around the world to bring impactful breakthroughs and therapies to market faster. Azenta is headquartered in Burlington, MA, with operations in North America, Europe and Asia For more information visit www.Azenta.com.

The Alkek Center for Metagenomics and Microbiome Research (CMMR), based in Houston Texas, was launched in 2011 as an integral part of the Baylor College of Medicine strategic plan and has since served as a hub for translational microbiome research. Over the past 13 years, the CMMR has collaborated on more than 500 projects with over 300 research groups from around the world, offering sequencing and analytical services for researchers focusing on human microbiome and virome research. Our team of scientists provide a full end-to-end service to our collaborators, from expertise in study design, sample collection and processing, metagenomic/metatranscriptomic sequencing and analysis with data interpretation, to single bacterial and viral strain sequencing and annotation.

ZOTZ | KLIMAS is one of Germany’s leading, privately owned providers of interdisciplinary medical laboratory diagnostics, spanning cytology, pathology, genetics, and lab medicine. Operating across more than 20 locations nationwide, our network includes medical practices and laboratories, ensuring accessibility and convenience for our partners, patients, and healthcare professionals.

At ZOTZ | KLIMAS, we offer a holistic suite of medical and diagnostic consulting services, facilitated by specialized physicians and cutting-edge lab technology. From single gene analysis to multi-gene panels, clinical exome, and whole exome analyses, we deliver a comprehensive array of methods tailored to meet your unique needs.

With a commitment to efficiency and excellence, we pride ourselves on swift turnaround times for analyses, accompanied by high-quality reports and personalized therapy recommendations from our expert physicians in human genetics. Our collaborative approach extends across disciplines, fostering interdisciplinary teamwork and ensuring comprehensive solutions across Human Genetics, Molecular Pathology, and Laboratory Diagnostics.

Enigma Genomics is a pioneer in genomic and precision medicine that has pioneered the use of advanced machine-learning frameworks and cutting-edge sequencing approaches to transform raw genetic data into invaluable knowledge that not only brings hope to those affected by genetic diseases but also provides unparalleled opportunities to predict health outcomes. Enigma Genomics, based in Saudi Arabia, is fully accredited by local and national accreditation entities and has a world-class team comprising experts in genomics, bioinformatics, machine learning, information technology, and business management, which has crafted an innovative end-to-end genetic data analysis framework. 

The Genomics Core Facility (GCF) at Newcastle University is a state-of-the-art next-generation sequencing (NGS) lab specialising in single-cell and spatial transcriptomic applications. Routinely delivered high-throughput genomic services include, transcriptome, exome, genome, and targeted methylation sequencing. Sequencing technologies include, Illumina (MiSeq, NextSeq 500, NovaSeq 6000) and Oxford Nanopore Technologies (PromethION 24) platforms. The team has extensive NGS project management experience and work with clients across diagnostic, academic, government, and commercial sectors.

The GCF have been using Twist Bioscience exome panels since 2018 and methylation panels since 2022.

Genomics is Taiwan's biggest commercial genome sequencing company, with a solid foundation of existing technology services, to develop accurate medical genetic testing, for personalized medical information. “Genomics” originally means the science to study genomics. The company uses “Genomics” as the name to establish a genomic research platform, mainly providing professional technological services. Genomics is devoted to the development of basic research and application of genomics, in the hope of contributing to the solutions for various issues related to our daily lives such as Grain yield, development of new drugs, disease detection and treatment through the cooperation with related research institutions and industries.

Gene by Gene is a CAP-accredited and CLIA-certified genetic testing laboratory located in Houston, TX. With over 20 years of experience, Gene by Gene is recognized globally by its partners for its outstanding expertise in delivering innovative and affordable genetic testing services.

Gene by Gene has developed lab processes that are scalable and modular to support the growth of its partners, whether that be through product addition or volume expansion. Additionally, we are a full-service laboratory, offering fulfillment, collection kit options, lab services, biobanking, and/or reporting. We can be a company's one-stop-shop or you can pick and choose the services that are desired by you.

CyberomiX (CX) is a new face of genomics service provider established by one of key opinion leaders of genomics in Japan and provides one-stop solutions of genomics from design of the study, sample/library-prep to bioinformatics. CX service also features full-customized experiment and data analysis because CX mind is based on “beyond academia”.

Diagenode is a leading global provider of complete solutions for epigenetics research from biomarker discovery to biomarker validation. Headquartered in Belgium, we have subsidiaries in both the US and Japan to serve customers worldwide including North America, Europe, Japan, and nearly all countries globally. Our full end-to-end epigenomics profiling services for the human methylome and custom panel, powered by Twist technology, include project design with our experts, sample preparation, sequencing, and bioinformatics analysis. A variety of sample types can be processed including blood, plasma cell-free DNA, urine, frozen tissue, FFPE, and cells with DNA sample inputs ranging from 200ng down to 10ng.

CeGaT’s vision is to make next-generation sequencing available to all life scientists and to bring diagnostic knowledge into sequencing services. Within the research and pharmaceutical industry, CeGaT offers a broad portfolio of sequencing services and tumor analysis. As a pioneer in NGS-based genetic diagnostics, CeGaT has a profound understanding of the underlying technology. In order to get the best result and assure premium quality, the company applies state-of-the-art sequencing technology, combined with outstanding customer care and an interdisciplinary team.

CeGat also has CLIA & CAP accreditation and the DIN EN ISO/IEC 17025 accreditation.

Services we can provide: Next-Generation and long-read sequencing services in the fields of Genomics, Transcriptomics, Microbiome Analysis, Translational Oncology, Immunology, and Pharma Solutions.

Azenta Life Sciences is dedicated to enabling life sciences organizations around the world to bring impactful breakthroughs and therapies to market – faster. Azenta encapsulates our commitment to helping customers reach new heights in their pursuit of scientific progress. By integrating our industry-leading capabilities, Azenta Life Sciences enterprise-wide sample exploration and management solutions will accelerate discovery, development and delivery, with greater speed and precision. At Azenta, we strive to keep elevating each other, our customers’ work and our industry – building a healthier world for people everywhere.

Please change the company name "Public Interest Incorporated Foundation CiRA Foundation".　 

Public Interest Incorporated Foundation CiRA Foundation performs quality evaluation tests of samples related to iPS cells, iPS cell-derived differentiated cells, and research and medical applications using iPS cells. You can choose from various test items, including viability, expression of undifferentiated markers, residual plasmid tests, and whole-genome analysis. We also construct test systems, so please don't hesitate to contact us.

The Genome Information Research Center, Research Institute for Microbial Diseases, Osaka University, has prepared various next-generation sequencers and proposes optimal analysis conditions tailored to the needs of researchers, providing technical support for genetic analysis. Our center is certified by Illumina Inc.'s Propel and Twist Bioscience's ProLab as a service provider. We provide contract analysis for a wide range of applications, including single-cell analysis, spatial transcriptome analysis, metagenomic analysis, RNA-Seq (mRNA-Seq, miRNA-Seq, etc.), whole-exome sequencing (WES), and whole-genome sequencing (WGS), as well as support through experimental design to publication. Please feel free to contact us.

Company Profile/Introduction: M Diagnostics is a PHMC-licensed clinical diagnostic laboratory that is a part of the MiRXES Group. MiRXES is a Singapore-headquartered biotech company whose mission is to save and improve lives through early, actionable, and personalized diagnoses. The vision for M Diagnostics is to be a world-renowned specialty clinical laboratory focused on translating the latest genomic science and multi-omics technologies into the clinic.

Genomed SA is the undisputed leader of NGS in Poland and the provider of the most advanced NGS services, including a wide range and complex bioinformatic analysis. The Genomed offer is universal. In the diagnostic section, it includes genetic testing for individual patients, hospitals and clinics, physicians running private practice, centers performing clinical studies. And in its scientific part – it is addressed to the scientific community, pharmaceutical and biotechnology companies.

PHRI's mission is to conduct research that improves major health outcomes for people around the world. Through international collaboration and innovation, PHRI explores CVD, diabetes, kidney and lung diseases, brain health, cancer and more.

Center for Translational Genomics (CTG) is a research infrastructure and technical platform for Next Generation Sequencing (NGS) and other genomics technologies at the Medical Faculty of Lund University. CTG offers expertise and service in genomic technologies to promote translational research projects or projects aiming at clinical implementation of new diagnostic assays in healthcare.

The company's mission is to provide affordable and applicable molecular genetic analyses and technical solutions to the professional health sector, to universities, biotech firms, private clinics, and individuals.

Amplexa Genetics offers a range of molecular technical solutions with Illumina state-of-the-art instruments and cutting-edge NGS technologies combined with in-house bioinformatic knowledge. We deliver genetic tests, ranging from specialized clinical genetic analyses to carrier screening, preconception testing, and prenatal testing. These tests can help identify disease causes and allow for targeted treatment, but they can also identify the risk of passing on genetic conditions to future generations and provide valuable information for family planning and medical management.

Psomagen, Inc., formerly Macrogen U.S.A., is a North American integrative omics solutions and contract laboratory services provider. The company makes cutting-edge technology and data analysis accessible to the academic, pharma, biotech and clinical markets. With both CLIA-certified and CAP-accredited facilities, its team delivers the highest-quality multiomics data using best-in-class DNA, RNA, and protein analysis systems. In conjunction with its bioinformatics capabilities, Psomagen offers a path to insights that is both simple and affordable. Learn more at psomagen.com.

GenomeScan is a core genetic QC facility for multiple pharmaceutical and biotechnology companies specializing in antibody, vaccine and gene therapy manufacturing. We offer a wide range of solutions that meet our clients' specific needs, including genetic characterization, microbial identification, viral safety testing, and mycoplasma detection. Our assays are designed to be fast, accurate, and cost-effective, helping our partners to save time and resources in the development and commercialization of their products.

Our 20+ years of experience in the industry and strong, in-house expertise in NGS coupled with robust bioinformatics pipelines let us stand out with the quality of our services. Additionally, short turnaround times and workflows that adhere to ISO/IEC 17025, ISO15189, and GMP guidelines help you advance to the next stage of your development and production programs with confidence. To learn more about GenomeScan, visit www.genomescan.nl

Admera is a leading partner in delivering innovative next-generation sequencing solutions within a rigorous clinical-grade environment. Our deep expertise, combined with the power of Twist Bioscience tools, drives groundbreaking research and achieves remarkable outcomes. Admera is committed to the relentless pursuit of research success and discovery by utilizing state-of-the-art platforms. All samples undergo meticulous processing in our facility in New Jersey, United States. This ensures the highest quality and adheres to our rigorous CLIA/CLEP-certified and CAP-accredited environment.

Founded in 2006, LC-Bio has been deeply focused on genetic technology. Guided by the vision of "Decoding Life's Mysteries, Scripting Life's Stories", it builds on its continuously innovated and independently developed core genetic technologies. The company is dedicated to exploring and expanding the application of genetic technologies across diverse scenarios and driving their industrialization and practical implementation. Leveraging high-throughput sequencing and bioinformatics technologies, it provides life science and medical research clients with multifaceted, cutting-edge, and consistently reliable research services and solutions.

At LifeStrands Genomics, we believe that everyone should have access to better healthcare through advancement of clinical genomics.

Our accredited laboratories with a dedicated team of medical professionals work together to deliver high quality and reliable solutions for clinicians and their patients.

Our team of scientists and cutting-edge equipment enable us to deliver a spectrum of translational genomics research services including population genomics, microbiome or biomarker discovery leveraging the latest advancements in next generation sequencing.

Connect with us to find out more.

The Genomics Core Facility (NorSeq-Cancer) at the Institute for Cancer Research at Oslo University Hospital has over 25 years of experience delivering state-of-the-art high-through genomic services to study the genome, epigenome and transcriptome in basic, translational and clinical research projects. We have developed a wide range of laboratory protocols that scale to different project sizes. We provide end-to-end solutions from experimental design with our technology experts, sample preparation, sequencing and bioinformatic analysis. Our services are offered for a wide variety of sample types and inputs, including blood, liquid biopsies, FFPE, fresh frozen material, cell lines, and more.